Edesa BiotechEDSA
13F holders, Q2 2024 (June 30)17holders
2new positions
2sold out
$4.28avg. 13F price*
At the end of Q2 2024, 17 institutions reported holding Edesa Biotech Inc. (EDSA) in their 13F filings, unchanged from Q1 2024. 2 opened new positions and 2 sold out. The largest holders were CM Management, LLC ($385K), Geode Capital Management, LLC ($78K) and Vanguard Group Inc. ($68K).
- Company
- Edesa Biotech Inc.
- CUSIP
- 27966L306
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $46K |
| Exits | 2 | $660 |
All 13F filers, Q1 2024 → Q2 2024: 42,994 shares bought and 159 shares sold, net +42,835 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 17 holders
| CM Management, LLC | 0.35% | Add +45.2% | 90,000 | $385K |
| Geode Capital Management, LLC | 0.00% | Add +26.6% | 18,219 | $78K |
| Vanguard Group Inc. | 0.00% | No change | 15,864 | $68K |
| Dimensional Fund Advisors LP | 0.00% | No change | 11,333 | $49K |
| Cibc World Market Inc. | 0.00% | New | 10,770 | $46K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +17.9% | 2,446 | $10K |
| Royal Bank of Canada | 0.00% | No change | 1,737 | $7K |
| TD Waterhouse Canada Inc. | 0.00% | No change | 142 | $596 |
| Fifth Third Bancorp | 0.00% | No change | 100 | $428 |
| Morgan Stanley | 0.00% | No change | 28 | $120 |
| Global Retirement Partners, LLC | 0.00% | No change | 25 | $107 |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 19 | $81 |
| Bank of America Corp. | 0.00% | New | 18 | $77 |
| National Bank of Canada | 0.00% | No change | 8 | $33 |
| UBS Group AG | 0.00% | No change | 4 | $17 |
| Credit Agricole S A | 0.00% | No change | 1 | $4 |
| AllSquare Wealth Management LLC | 0.00% | No change | 1 | $4 |
"% of holder's portfolio" is EDSA's weight in each manager's 13F, not the share of Edesa Biotech Inc. the manager owns.